Mistelle Locke
Known title: DirectorCIK: 0001960753
Associated companies
Transaction History
| DRCT | ▲ Buy | Option Exercise | 37 | — | 6/12/2026 | View on chart |
| DRCT | ▼ Sell | Open Market | 25 | $73 | 6/12/2026 | View on chart |
| DRCT | ▲ Buy | Option Exercise | 159 | — | 6/9/2026 | View on chart |
| DRCT | ▼ Sell | Open Market | 76 | $225 | 6/9/2026 | View on chart |
| DRCT | ▲ Buy | Option Exercise | 90 | — | 1/24/2026 | View on chart |
| DRCT | ▲ Buy | Option Exercise | 34 | — | 1/16/2026 | View on chart |
| DRCT | ▼ Sell | Open Market | 31 | $202 | 1/16/2026 | View on chart |
| DRCT | ▲ Buy | Option Exercise | 8,205 | — | 6/12/2025 | View on chart |
| DRCT | ▼ Sell | Open Market | 3,432 | $2K | 6/12/2025 | View on chart |
| DRCT | ▲ Buy | Option Exercise | 7,246 | — | 1/16/2025 | View on chart |
| DRCT | ▼ Sell | Open Market | 1,773 | $2K | 1/16/2025 | View on chart |
| DRCT | ▼ Sell | Open Market | 7,048 | $6K | 12/18/2024 | View on chart |
| DRCT | ▲ Buy | Grant | 24,615 | $0 | 12/9/2024 | View on chart |
| DRCT | ▼ Sell | Open Market | 1,098 | $6K | 6/14/2024 | View on chart |
| DRCT | ▲ Buy | Option Exercise | 8,205 | — | 6/12/2024 | View on chart |
| DRCT | ▼ Sell | Tax Withholding | 1,719 | $20K | 1/25/2024 | View on chart |
| DRCT | ▲ Buy | Option Exercise | 7,246 | — | 1/16/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
DRCT shows after-hours activity and tops Friday's gainers list
DRCT traded after the close on Friday, generating a volume spike and moving into a high‑beta zone. The stock also appeared among the day's top gainers, indicating increased after‑hours interest. Its RSI of 31.2 suggests it is not yet overbought, and the $2.54 support level remains a key reference point.
DRCT shows after-hours activity and tops Friday's gainers list. DRCT traded after the close on Friday, generating a volume spike and moving into a high‑beta zone. The stock also appeared among the day's top gainers, indicating increased after‑hours interest. Its RSI of 31.2 suggests it is not yet overbought, and the $2.54 support level remains a key reference point.